Life Science REIT

LABSReal Estate
43.87GBX
0.61%
Market Cap
154.24M
Volume
10.44k
1% of avg
P/E Ratio
EPS (TTM)
Beta
-0.08
Day Range
43.10p - 43.87p
52 Week Range
31.30p43.87p47.10p
43.87p

Upcoming Events

3 June 2025
Annual General Meeting
June 2026
Debt facility maturity
High Impact Event
31 December 2027
Transitional arrangement for fee calculation ends
LABS
NEUTRAL

Life Science REIT PLC Announces Holding(s) in Company

The real estate investment trust has received a notification of a change in major shareholding.

LABS
NEUTRAL

Life Science REIT Provides Notice of Annual General Meeting

The real estate investment trust has announced the details of its upcoming annual general meeting, including the date, time, and location.

LABS
NEUTRAL

Life Science REIT PLC Announces Holding(s) in Company

The real estate investment trust has received a notification of a change in major shareholding.

LABS
BAD

Life Science REIT Announces Strategic Review Amid Challenging Market Conditions

This real estate investment trust faces significant challenges, including suspended dividends and material uncertainty about its future operations, despite some improvements in occupancy and revenue.

LABS
VERY GOOD

Life Science REIT Secures New Lease at Oxford Technology Park, Setting Rental Record

The real estate investment trust has signed a new 10-year lease agreement for 5,600 sq. ft. of space at the Oxford Technology Park, setting a new rental record for the park.

LABS
NEUTRAL

Life Science REIT Announces Regulatory Disclosure

The healthcare REIT has announced a regulatory disclosure regarding a change in major shareholding.

LABS
NEUTRAL

Life Science REIT Announces Regulatory Threshold Change

The healthcare REIT has announced a change in regulatory shareholding thresholds, with BlackRock's stake falling below 5%.

LABS
GOOD

Life Science REIT Amends Investment Advisory Agreement, Saving £1M Annually

The property investment firm has revised its investment advisory agreement, resulting in an annual saving of £1 million. This should boost the company's profitability.

LABS
NEUTRAL

Life Science REIT Announces Director Dealings

The real estate investment trust has disclosed changes to its major shareholders.

LABS
BAD

Life Science REIT Launches Strategic Review, Suspends Dividends

The property business focused on the UK's life science sector has launched a strategic review, including a formal sale process, after facing challenges since its IPO that have impacted its share price and financial performance.